Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Terminated 4Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 4Thoracic 1

Conditions

Venous Thromboembolism 4Neoplasms 3Venous Thrombosis 2Thrombosis 1Pulmonary Embolism 1Lung Neoplasms 1

Interventions

Dalteparin 5Tinzaparin 4apixaban 2abelacimab 2Nadroparin 2MAA868 2Heparin, Low-Molecular-Weight 2Enoxaparin 2reviparin 1certoparin 1bemiparin 1acarboxyprothrombin 1Warfarin 1Rivaroxaban 1Platelet Transfusion 1Phenprocoumon 1Mass Screening 1Hematologic Tests 1Aspirin 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Venous Thromboembolism × Tinzaparin × Clear all
NCT03090880 2022-11-17

PROVE

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
59 enrolled
Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT00981903 2017-07-06

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

University of Southern California

Phase 2 Terminated
131 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡